The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Physiological and pathological phosphorylation of tau by Cdk5
Open accessAbstract
Hyperphosphorylation of microtubule-associated protein tau is one of the major pathological events in Alzheimer's disease (AD) and other related neurodegenerative diseases, including frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17). Mutations in the tau gene MAPT are a cause of FTDP-17, and the mutated tau proteins are hyperphosphorylated in patient brains. Thus, it is important to determine the molecular mechanism of hyperphosphorylation of tau to understand the pathology of these diseases collectively called tauopathy. Tau is phosphorylated at many sites via several protein kinases, and a characteristic is phosphorylation at Ser/Thr residues in Ser/Thr-Pro sequences, which are targeted by proline-directed protein kinases such as ERK, GSK3β, and Cdk5. Among these kinases, Cdk5 is particularly interesting because it could be abnormally activated in AD. Cdk5 is a member of the cyclin-dependent kinases (Cdks), but in contrast to the major Cdks, which promote cell cycle progression in proliferating cells, Cdk5 is activated in post-mitotic neurons via the neuron-specific activator p35. Cdk5-p35 plays a critical role in brain development and physiological synaptic activity. In contrast, in disease brains, Cdk5 is thought to be hyperactivated by p25, which is the N-terminal truncated form of p35 and is generated by cleavage with calpain. Several reports have indicated that tau is hyperphosphorylated by Cdk5-p25. However, normal and abnormal phosphorylation of tau by Cdk5 is still not completely understood. In this article, we summarize the physiological and pathological phosphorylation of tau via Cdk5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
The mitogen-activated protein kinase signal transduction pathway
Davis, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82362-6 · Cited by 2,139
The distribution of tau in the mammalian central nervous system.
Binder, L. I., Frankfurter, A., & Rebhun, L. I. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.4.1371 · Cited by 1,588
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L.-H. (1999) · Nature · doi:10.1038/45159 · Cited by 1,545
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Neurotoxicity induces cleavage of p35 to p25 by calpain
Lee, M.-S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., & Tsai, L.-H. (2000) · Nature · doi:10.1038/35012636 · Cited by 1,063
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037 · cited 1×
“A number of neurodegenerative diseases with tau aggregates are collectively known as tauopathy (Iqbal et al., 2005; Spillantini and Goedert, 2013).”
BackgroundGoedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006 · cited 2×
“Major pathological hallmarks of AD include senile plaques and neurofibrillary tangles (NFT), which consist mainly of amyloid β peptide (Aβ) and hyperphosphorylated tau, respectively (Mattson, 1997; Bettens et al., 2010).”
BackgroundInfluentialThe MAP1 family of microtubule-associated proteins.
Dehmelt (2004) · Genome biology · doi:10.1186/gb-2004-6-1-204 · Cited by 972
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965
A family of human cdc2-related protein kinases.
Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., & Tsai, L. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 923
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Tsai, L.-H., Delalle, I., Caviness, V. S., Chae, T., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 922
A human peptidyl–prolyl isomerase essential for regulation of mitosis
Ping Lu, K., Hanes, S. D., & Hunter, T. (1996) · Nature · doi:10.1038/380544a0 · Cited by 904
Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899
The Genetics of Alzheimer Disease: Back to the Future
Bertram, L., Lill, C. M., & Tanzi, R. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.013 · Cited by 834
The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P. (1999) · Nature · doi:10.1038/21650 · Cited by 721
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
Zempel, H., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2357-10.2010 · Cited by 686 · cited 1×
“…when neurons suffer from various neurotoxic insults, such as Aβ (Otth et al., 2002; Han et al., 2005; Zheng et al., 2005, 2010; Lopes et al., 2007; Zempel et al., 2010; Shukla et al., 2012), ischemia/hypoxia (Wen et al., 2007; Barros-Miñones et al., 2013), oxidative stress (Absalon et al.,…”
BackgroundThe prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease
Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley–Whyte, E. T., Frosch, M. P., Albert, M. S., Hyman, B. T., & Irizarry, M. C. (2004) · Neurology · doi:10.1212/01.wnl.0000115115.98960.37 · Cited by 666
Gong, C.-X., & Iqbal, K. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785909111 · Cited by 644
Tau phosphorylation in neuronal cell function and dysfunction
Johnson, G. V. W., & Stoothoff, W. H. (2004) · Journal of Cell Science · doi:10.1242/jcs.01558 · Cited by 624
Cruz, J. C., Tseng, H.-C., Goldman, J. A., Shih, H., & Tsai, L.-H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00627-5 · Cited by 609
A brain-specific activator of cyclin-dependent kinase 5
Lew, J., Huang, Q.-Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., & Wang, J. H. (1994) · Nature · doi:10.1038/371423a0 · Cited by 579
Proline-directed and non-proline-directed phosphorylation of PHF-tau
Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., & Ihara, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.823 · Cited by 557
Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo
Noble, W., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J., Gaynor, K., LaFrancois, J., Wang, L., Kondo, T., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00259-9 · Cited by 509
Tau filament formation in transgenic mice expressing P301L tau
Götz, J., Chen, F., Barmettler, R., & Nitsch, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006531200 · Cited by 495
Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies
Spillantini, M. G., Bird, T. D., & Ghetti, B. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00162.x · Cited by 475
Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455
Shen, W., Plotkin, J. L., Francardo, V., Ko, W. K. D., Xie, Z., Li, Q., Fieblinger, T., Wess, J., Neubig, R. R., Lindsley, C. W., et al. (2015) · HAL (Le Centre pour la Communication Scientifique Directe) · doi:10.1016/j.neuron · Cited by 452
Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration
Liou, Y.-C., Sun, A., Ryo, A., Zhou, X. Z., Yu, Z.-X., Huang, H.-K., Uchida, T., Bronson, R., Bing, G., Li, X., et al. (2003) · Nature · doi:10.1038/nature01832 · Cited by 435
Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain
Hasegawa, M., Morishima-Kawashima, M., Takio, K., Suzuki, M., Titani, K., & Ihara, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41890-x · Cited by 430
Calpain-dependent Proteolytic Cleavage of the p35 Cyclin-dependent Kinase 5 Activator to p25
Kusakawa, G.-I., Saito, T., Onuki, R., Ishiguro, K., Kishimoto, T., & Hisanaga, S.-I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907757199 · Cited by 381
Self-citationHo, P. I., Ortiz, D., Rogers, E., & Shea, T. B. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10416 · Cited by 381
Calpains — An elaborate proteolytic system
Ono, Y., & Sorimachi, H. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.08.005 · Cited by 349
Ahlijanian, M. K., Barrezueta, N. X., Williams, R. D., Jakowski, A., Kowsz, K. P., McCarthy, S., Coskran, T., Carlo, A., Seymour, P. A., Burkhardt, J. E., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040577797 · Cited by 341
The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation
Plattner, F., Angelo, M., & Giese, K. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603469200 · Cited by 340
An Isoform of the Neuronal Cyclin-dependent Kinase 5 (Cdk5) Activator
Tang, D., Yeung, J., Lee, K.-Y., Matsushita, M., Matsui, H., Tomizawa, K., Hatase, O., & Wang, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26897 · Cited by 340
Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations
Alonso, A. D. C., Mederlyova, A., Novak, M., Grundke-Iqbal, I., & Iqbal, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405131200 · Cited by 329
Patrick, G. N., Zhou, P., Kwon, Y. T., Howley, P. M., & Tsai, L.-H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24057 · Cited by 312
Tau domains, phosphorylation, and interactions with microtubules
Mandelkow, E.-M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B., & Mandelkow, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00025-a · Cited by 308
Protein phosphatase 2A dysfunction in Alzheimer’s disease
Sontag, J.-M., & Sontag, E. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00016 · Cited by 304
Illenberger, S., Zheng-Fischhöfer, Q., Preuss, U., Stamer, K., Baumann, K., Trinczek, B., Biernat, J., Godemann, R., Mandelkow, E.-M., & Mandelkow, E. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.6.1495 · Cited by 304
Absalon, S., Kochanek, D. M., Raghavan, V., & Krichevsky, A. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1327-13.2013 · Cited by 302 · cited 1×
“…Zheng et al., 2005, 2010; Lopes et al., 2007; Zempel et al., 2010; Shukla et al., 2012), ischemia/hypoxia (Wen et al., 2007; Barros-Miñones et al., 2013), oxidative stress (Absalon et al., 2013), inflammation (Quintanilla et al., 2004; Kitazawa et al., 2005), and excitotoxicity (Ho et al., 2002).”
BackgroundPhysiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori, K., & Uchida, T. (1997) · PubMed · Cited by 288
Paudel, H. K., Lew, J., Ali, Z., & Wang, J. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49492-1 · Cited by 285
Structure and Regulation of the CDK5-p25nck5a Complex
Tarricone, C., Dhavan, R., Peng, J., Areces, L. B., Tsai, L.-H., & Musacchio, A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00343-4 · Cited by 280
Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression.
Hellmich, M. R., Pant, H. C., Wada, E., & Battey, J. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10867 · Cited by 278
Tatebayashi, Y., Miyasaka, T., Chui, D.-H., Akagi, T., Mishima, K.-I., Iwasaki, K., Fujiwara, M., Tanemura, K., Murayama, M., Ishiguro, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202205599 · Cited by 272
Self-citationCdk5 deregulation in the pathogenesis of Alzheimer's disease
Cruz, J. C., & Tsai, L.-H. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.001 · Cited by 258
Purification and characterization of a novel proline-directed protein kinase from bovine brain.
Lew, J., Beaudette, K., Litwin, C. M., & Wang, J. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42222-3 · Cited by 241
Has the Amyloid Cascade Hypothesis for Alzheimers Disease been Proved?
Hardy, J. (2006) · Current Alzheimer Research · doi:10.2174/156720506775697098 · Cited by 241
Neurodegeneration with Tau Accumulation in a Transgenic Mouse Expressing V337M Human Tau
Tanemura, K., Murayama, M., Akagi, T., Hashikawa, T., Tominaga, T., Ichikawa, M., Yamaguchi, H., & Takashima, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00133.2002 · Cited by 233
In vivo phosphorylation sites in fetal and adult rat tau
Watanabe, A., Hasegawa, M., Suzuki, M., Takio, K., Morishima-Kawashima, M., Titani, K., Arai, T., Kosik, K. S., & Ihara, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74447-0 · Cited by 231
Shetty, K. T., Link, W. T., & Pant, H. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6844 · Cited by 206
Nukina, N., Kosik, K. S., & Selkoe, D. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3415 · Cited by 198
Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK‐3β
Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.-X. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03487-7 · Cited by 196
A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons
Zheng, Y., Kesavapany, S., Gravell, M., Hamilton, R. S., Schubert, M., Amin, N., Albers, W., Grant, P., & Pant, H. C. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600441 · Cited by 189
Deregulated Cdk5 activity is involved in inducing Alzheimer's disease
Shukla, V., Skuntz, S., & Pant, H. C. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.015 · Cited by 185 · cited 1×
“…from various neurotoxic insults, such as Aβ (Otth et al., 2002; Han et al., 2005; Zheng et al., 2005, 2010; Lopes et al., 2007; Zempel et al., 2010; Shukla et al., 2012), ischemia/hypoxia (Wen et al., 2007; Barros-Miñones et al., 2013), oxidative stress (Absalon et al., 2013), inflammation…”
BackgroundAbnormal Tau-Containing Filaments in Neurodegenerative Diseases
Crowther, R. A., & Goedert, M. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4270 · Cited by 185
Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice
Piedrahita, D., Hernández, I., López-Tobón, A., Fedorov, D., Obara, B., Manjunath, B. S., Boudreau, R. L., Davidson, B., LaFerla, F., Gallego-Gómez, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3637-10.2010 · Cited by 183
Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases
Yu, Y., Run, X., Liang, Z., Li, Y., Liu, F., Liu, Y., Iqbal, K., Grundke‐Iqbal, I., & Gong, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05882.x · Cited by 173
Lichtenberg-Kraag, B., Mandelkow�, E., Biernat, J., Steiner, B., Schröter, C., Gustke, N., Meyer, H. E., & Mandelkow�, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5384 · Cited by 171
Current status on Alzheimer disease molecular genetics: from past, to present, to future
Bettens, K., Sleegers, K., & Van Broeckhoven, C. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq142 · Cited by 169
Götz, J., Schild, A., Hoerndli, F. J., & Pennanen, L. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.013 · Cited by 167
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats
Wen, Y., Yang, S.-H., Liu, R., Perez, E. J., Brun-Zinkernagel, A. M., Koulen, P., & Simpkins, J. W. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.011 · Cited by 162
Ishiguro, K., Omori, A., Takamatsu, M., Sato, K., Arioka, M., Uchida, T., & Imahori, K. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90839-y · Cited by 161
Self-citationPotentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
Sengupta, A., Wu, Q., Grundke-Iqbal, I., Iqbal, K., & Singh, T. J. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006883924775 · Cited by 160
Li, T., Hawkes, C. A., Qureshi, H. Y., Kar, S., & Paudel, H. K. (2006) · Biochemistry · doi:10.1021/bi051635j · Cited by 156
Stiff microtubules and neuronal morphology
Matus, A. I. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90030-2 · Cited by 151
Truncation of CDK5 Activator p35 Induces Intensive Phosphorylation of Ser202/Thr205 of Human Tau
Hashiguchi, M., Saito, T., Hisanaga, S., & Hashiguchi, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207426200 · Cited by 149
Self-citationTransgenic animal models of tauopathies
Lee, V. M. ‐., Kenyon, T. K., & Trojanowski, J. Q. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.014 · Cited by 148
Calpain-mediated Cleavage of the Cyclin-dependent Kinase-5 Activator p39 to p29
Patzke, H., & Tsai, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109645200 · Cited by 147
Wen, Y., Planel, E., Herman, M., Figueroa, H. Y., Wang, L., Liu, L., Lau, L.-F., Yu, W. H., & Duff, K. E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5245-07.2008 · Cited by 145
Gauthier‐Kemper, A., Weissmann, C., Golovyashkina, N., Sebö-Lemke, Z., Drewes, G., Gerke, V., Heinisch, J. J., & Brandt, R. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201007161 · Cited by 142
Hisanaga, S., Kusubata, M., Okumura, E., & Kishimoto, T. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54707-4 · Cited by 140
Self-citationAβPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576
Otth, C., Concha, I. I., Arendt, T., Stieler, J., Schliebs, R., González-Billault, C. E., & Maccioni, R. B. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4508 · Cited by 132
Substrate specificity characterization of a cdc2-like protein kinase purified from bovine brain.
Beaudette, K. N., Lew, J., & Wang, J. H.-C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36859-0 · Cited by 128
Regulation and role of cyclin‐dependent kinase activity in neuronal survival and death
Hisanaga, S., & Endo, R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07050.x · Cited by 121
Self-citationAccumulation of Filamentous Tau in the Cerebral Cortex of Human Tau R406W Transgenic Mice
Ikeda, M., Kawarai, T., Kawarabayashi, T., Matsubara, E., Murakami, T., Sasaki, A., Tomidokoro, Y., Ikarashi, Y., Kuribara, H., Ishiguro, K., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62274-2 · Cited by 120
Self-citationAsada, A., Yamamoto, N., Gohda, M., Saito, T., Hayashi, N., & Hisanaga, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05500.x · Cited by 119
Self-citationCyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells
Brinkkoetter, P. T., Olivier, P., Wu, J. S., Henderson, S., Krofft, R. D., Pippin, J. W., Hockenbery, D. M., Roberts, J. M., & Shankland, S. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37978 · Cited by 117
Goedert, M., Satumtira, S., Jakes, R., Smith, M. J., Kamibayashi, C., White, C. L., & Sontag, E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752155.x · Cited by 114
Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease
Engmann, O., & Giese, K.-P. (2009) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.002.2009 · Cited by 112
Hallows, J. L., Chen, K., DePinho, R. A., & Vincent, I. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10633.2003 · Cited by 112
Qi, R. Z., Huang, Q., Lee, K., Lew, J., & Wang, J. H.-C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10847 · Cited by 110
Extraneuronal roles of cyclin‐dependent kinase 5
Rosales, J. L., & Lee, K. (2006) · BioEssays · doi:10.1002/bies.20473 · Cited by 110
Han, P., Dou, F., Li, F., Zhang, X., Zhang, Y., Zheng, H., Lipton, S. A., Xu, H., & Liao, F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3831-05.2005 · Cited by 103
Hisanaga, S., Ishiguro, K., Uchida, T., Okumura, E., Okano, T., & Kishimoto, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82437-1 · Cited by 99
Self-citationZheng, Y., Amin, N. D., Hu, Y., Rudrabhatla, P., Shukla, V., Kanungo, J., Kesavapany, S., Grant, P. G., Albers, W., & Pant, H. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134643 · Cited by 97
Vandebroek, T., Vanhelmont, T., Terwel, D., Borghgraef, P., Lemaire, K., Snauwaert, J., Wera, S., LEUVEN, F. V., & Winderickx, J. (2005) · Biochemistry · doi:10.1021/bi0506775 · Cited by 90
The Peptidyl Prolyl cis/trans-Isomerase Pin1 Recognizes the Phospho-Thr212-Pro213 Site on Tau
Smet‐Nocca, C., Sambo, A., Wieruszeski, J., Leroy, A., Landrieu, I., Buée, L., & Lippens, G. M. (2004) · Biochemistry · doi:10.1021/bi035479x · Cited by 89
τ Protein Kinase II Is Involved in the Regulation of the Normal Phosphorylation State of τ Protein
Arioka, M., Tsukamoto, M., Ishiguro, K., Kato, R., Sato, K., Imahori, K., & Uchida, T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03173.x · Cited by 86
Self-citationA novel presenilin‐1 mutation: Increased β‐amyloid and neurofibrillary changes
Gómez‐Isla, T., Wasco, W., Pettingell, W. P., Gurubhagavatula, S., Schmidt, S. D., Jondro, P. D., McNamara, M. J., Rodes, L., Di-Blasi, T., Growdon, W. B., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410410618 · Cited by 82
Landrieu, I., Smet‐Nocca, C., Amniai, L., Louis, J. V., Wieruszeski, J., Goris, J., Janssens, V., & Lippens, G. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021521 · Cited by 81
Kimura, T., Tsutsumi, K., Taoka, M., Saito, T., Masuda‐Suzukake, M., Ishiguro, K., Plattner, F., Uchida, T., Isobe, T., Hasegawa, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.433326 · Cited by 80
Self-citationUchida, T., Ishiguro, K., Ohnuma, J., Takamatsu, M., Yonekura, S., & Imahori, K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01163-x · Cited by 80
Self-citationInvolvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain
Takashima, A., Murayama, M., Yasutake, K., Takahashi, H., Yokoyama, M., & Ishiguro, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01864-x · Cited by 79
Self-citationKinase activities increase during the development of tauopathy in htau mice
Kelleher, I., Garwood, C., Hanger, D. P., Anderton, B. H., & Noble, W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04930.x · Cited by 78
Kamei, H., Saito, T., Ozawa, M., Fujita, Y., Asada, A., Bibb, J. A., Saido, T. C., Sorimachi, H., & Hisanaga, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610541200 · Cited by 77
Self-citationLund, E. T., McKenna, R., EVANS, D. B., Sharma, S. K., & Mathews, W. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00130.x · Cited by 75
tau Assembly in Inducible Transfectants Expressing Wild-Type or FTDP-17 tau
Deture, M. A., Ko, L., Easson, C., & Yen, S.-H. C. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64448-3 · Cited by 71
Closing in on the Amyloid Cascade
Doms, R. W., & Huse, J. T. (2000) · Molecular Neurobiology · doi:10.1385/mn:22:1-3:081 · Cited by 66
Lopes, J. P., Oliveira, C. R., & Agostinho, P. M. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9224-3 · Cited by 65
Wada, Y., Ishiguro, K., Itoh, T. J., Uchida, T., Hotani, H., Saito, T., Kishimoto, T., & Hisanaga, S.-I. (1998) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022174 · Cited by 58
Self-citationSerine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast
Vanhelmont, T., Vandebroek, T., Vos, A. D., Terwel, D., Lemaire, K., Anandhakumar, J., Franssens, V., Swinnen, E., LEUVEN, F. V., & Winderickx, J. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00662.x · Cited by 57
Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576
Chauhan, N. B., Siegel, G. J., & Feinstein, D. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.014 · Cited by 54
Krishnamurthy, P., & Johnson, G. V. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311203200 · Cited by 53
Cyclin-Dependent Kinase 5 in Neurofilament Function and Regulation
Kesavapany, S., Li, B.-S., & Pant, H. C. (2003) · Neurosignals · doi:10.1159/000074627 · Cited by 53
No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro
Peterson, D. W., Ando, D. M., Taketa, D. A., Zhou, H., Dahlquist, F. W., & Lew, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912718107 · Cited by 53
Neuronal Cdc2-like kinases: Neuron-specific forms of Cdk5
Lee, K.-Y., Qi, R. Z., Yu, Y. P., & Wang, J. H.-C. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00048-4 · Cited by 49
Minegishi, S., Asada, A., Miyauchi, S., Fuchigami, T., Saito, T., & Hisanaga, S. (2010) · Biochemistry · doi:10.1021/bi100631f · Cited by 49
Self-citationPrabakaran, S., Everley, R. A., Landrieu, I., Wieruszeski, J., Lippens, G. M., Steen, H., & Gunawardena, J. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.15 · Cited by 48
Hisanaga, S., Uchiyama, M., Hosoi, T., Yamada, K., Honma, N., Ishiguro, K., Uchida, T., Dahl, D. R., Ohsumi, K., & Kishimoto, T. (1995) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970310405 · Cited by 48
Self-citationAsada, A., Saito, T., & Hisanaga, S. (2012) · Journal of Cell Science · doi:10.1242/jcs.100503 · Cited by 46
Self-citationAmniai, L., Lippens, G. M., & Landrieu, I. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.046 · Cited by 46
Okadaic Acid-Stimulated Degradation of p35, an Activator of CDK5, by Proteasome in Cultured Neurons
Saito, T., Ishiguro, K., Onuki, R., Nagai, Y., Kishimoto, T., & Hisanaga, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9739 · Cited by 43
Self-citationPhosphorylation of FTDP-17 Mutant tau by Cyclin-dependent Kinase 5 Complexed with p35, p25, or p39
Sakaue, F., Saito, T., Satō, Y., Asada, A., Ishiguro, K., Hasegawa, M., & Hisanaga, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504792200 · Cited by 41
Self-citationHan, D., Qureshi, H. Y., Lu, Y., & Paudel, H. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901095200 · Cited by 40
Identification of Substrate Binding Site of Cyclin-dependent Kinase 5
Sharma, P., Steinbach, P. J., Sharma, M., Amin, N. D., Barchi, J. J., & Pant, H. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9600 · Cited by 40
Driver, J. A., Zhou, X. Z., & Lu, K. P. (2014) · PubMed · Cited by 39
NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease
Landrieu, I., Leroy, A., Smet‐Nocca, C., Huvent, I., Amniai, L., Hamdane, M., Sibille, N., Buée, L., Wieruszeski, J., & Lippens, G. M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381006 · Cited by 35
Tau phosphorylation in hippocampus results in toxic gain-of-function
Ávila, J., de Barreda, E. G., Engel, T., Lucas, J. J., & Hernández, F. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380977 · Cited by 34
Involvement of microtubules in the regulation of neuronal growth cone morphologic remodeling
Gallo, G. (1998) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199805)35:2<141::aid-neu2>3.0.co;2-4 · Cited by 30
Barros-Miñones, L., Martin‐de‐Saavedra, M. D., Perez‐Alvarez, S., Orejana, L., Suquía, V., Goñi‐Allo, B., Hervías, I., López, M. G., Jordán, J., Aguirre, N., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.002 · Cited by 28
Effect of Pin1 or Microtubule Binding on Dephosphorylation of FTDP-17 Mutant Tau
Yotsumoto, K., Saito, T., Asada, A., Oikawa, T., Kimura, T., Uchida, C., Ishiguro, K., Uchida, T., Hasegawa, M., & Hisanaga, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003277 · Cited by 25
Self-citation
Cited by
Building Models of Brain Disorders with Three-Dimensional Organoids
Amin, N. D., & Paşca, S. P. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.007 · Cited by 312
Role of tau protein in Alzheimer’s disease: The prime pathological player
Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.327 · Cited by 278
Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
Folch, J., Petrov, D., Ettcheto, M., Abad, S., Sánchez-López, E., García, M. L., Olloquequi, J., Beas-Zarate, C., Auladell, C., & Camins, A. (2016) · Neural Plasticity · doi:10.1155/2016/8501693 · Cited by 270
“Some or all of these kinases contribute to the perpetuation of the phosphorylation of Tau in neurofibrillary tangles [73, 75–81].”
BackgroundThe Role of Cdk5 in Alzheimer’s Disease
Liu, S.-L., Wang, C., Jiang, T., Tan, L., Xing, A., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9369-x · Cited by 269
Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.006 · Cited by 258
Metadata
- Authors
- Kimura, T., Ishiguro, K., & Hisanaga, S.-I.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2014-07-15
- Volume
- 7
- Pages
- 65-65
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2022410893
- Cited by
- 297
- References
- 131
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.